Athira Pharma, Inc. (ATHA) Misses Q1 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Reports Of Blasts Across Iran's Southern Regions: State TV - Bloomberg
• DA Davidson Reiterates Underperform Rating on c3.ai (AI)
• Active options: AMD PFE PLTR SOFI GOOGL PBR MSTR HOOD SNDK MRVL